Feline Leukemia Test Kit

The product quantitatively detects FeLV content in cat serum/plasma through the use of fluorescent immunochromatography. Fundamental principle: The nitrocellulose membrane is marked with antibody A, which specifically recognizes the FeLV antigen, and lines T and C are drawn. Anti-B is sprayed onto the binding pad with an additional fluorescent nanomaterial that is capable of recognize FeLV with specificity. Initially, the FeLV in the sample is combined with the nanomaterial-labeled antibody B to form a complex. Subsequently, the complex and T-line antibody a combine to form a sandwich structure chromatographically upward. When the excitation light is irradiated, the nanomaterial emits a fluorescent signal, with the signal intensity being equivalent to that of the sample. The concentration of FeLV in exhibited a positive correlation. Consequently, the positive guidance of reliable and effective detection is instrumental in the prevention, diagnosis, and treatment of various conditions. Detailedinput:
output:Purpose of Detection: FeLV is a retrovirus that is prevalent on a global scale. After cats are infected with the virus, the risk of lymphoma and other tumors is significantly elevated. Additionally, the virus has the potential to induce abnormal blood coagulation or other blood diseases, such as regenerative/non-regenerative anemia, and to cause the immune system to collapse, resulting in hemolytic anemia, kidney disease, Glomerulonephritis, and other conditions.